Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 16 Sep 2020

Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid

in Thoracic Oncology

Antonio Calles
María Inmaculada Aparicio
Manuel Alva
Marianela Bringas
Natalia Gutierrez
Javier Soto
Marta Arregui
Victoria Clara Tirado
Enrique Luis Álvarez
María del Monte-Millán

Frontiers in Oncology

doi 10.3389/fonc.2020.01777

16,992 views
32 citations

Original Research

Published on 15 Sep 2020

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer

in Thoracic Oncology

Muyun Peng
Qi Huang
Wei Yin
Sichuang Tan
Chen Chen
Wenliang Liu
Jingqun Tang
Xiang Wang
Bingyu Zhang
Min Zou

Frontiers in Oncology

doi 10.3389/fonc.2020.561598

13,282 views
92 citations

Original Research

Published on 15 Sep 2020

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma

in Thoracic Oncology

Long-Hua Guo
Ming-Feng Zhang
He-Long Zhang
Jian-Ying Zhou
Xiao-Hong Cai
Yu Long
Qi-Sen Guo
Nong Yang
Jun Zhao
Zhan-Hong Xie

Frontiers in Oncology

doi 10.3389/fonc.2020.01568

8,672 views
2 citations

Original Research

Published on 15 Sep 2020

Integrated Analysis of lncRNA–Mediated ceRNA Network in Lung Adenocarcinoma

in Thoracic Oncology

Xianxian Wu
Zhilin Sui
Hongdian Zhang
Ying Wang
Zhentao Yu

Frontiers in Oncology

doi 10.3389/fonc.2020.554759

28,345 views
204 citations

Review

Published on 09 Sep 2020

The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review

in Thoracic Oncology

Eric Rozitis
Ben Johnson
Yuen Yee Cheng
Kenneth Lee

Frontiers in Oncology

doi 10.3389/fonc.2020.01742

9,373 views
21 citations

Systematic Review

Published on 08 Sep 2020

The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Yanning Wang
Liyun Miao
Yuxuan Hu
Yujie Zhou

Frontiers in Oncology

doi 10.3389/fonc.2020.01636

5,752 views
21 citations

Case Report

Published on 08 Sep 2020

Effective Treatment With Afatinib of Lung Adenocarcinoma With Leptomeningeal Metastasis Harboring the Exon 18 p.G719A Mutation in the EGFR Gene Was Detected in Cerebrospinal Fluid: A Case Report

in Thoracic Oncology

Chunhua Ma
Shuyuan Wang
Ning Mu
Jinduo Li
Mei Liu
Lin Li
Rong Jiang

Frontiers in Oncology

doi 10.3389/fonc.2020.01635

4,255 views
3 citations

Original Research

Published on 08 Sep 2020

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Huabin Hu
Longjiang She
Mengting Liao
Yin Shi
Linli Yao
Dong Ding
Youwen Zhu
Shan Zeng
David P. Carbone
Jin Huang

Frontiers in Oncology

doi 10.3389/fonc.2020.01649

8,729 views
40 citations

Original Research

Published on 07 Sep 2020

Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents

in Thoracic Oncology

Mariona Riudavets
Joaquin Mosquera
Rosario Garcia-Campelo
Jorgina Serra
Georgia Anguera
Pablo Gallardo
Ivana Sullivan
Andrés Barba
Luís del Carpio
Agustí Barnadas

Frontiers in Oncology

doi 10.3389/fonc.2020.01677

7,348 views
54 citations

Original Research

Published on 02 Sep 2020

Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting

in Thoracic Oncology

Vicente Escudero-Vilaplana
Antonio Calles
Roberto Collado-Borrell
María Belén Marzal-Alfaro
Carlos Polanco
Carmen Garrido
Jorge Suarez
Aurora Ortiz
Marilena Appierto
Marta Comellas

Frontiers in Oncology

doi 10.3389/fonc.2020.01645

4,175 views
12 citations

Original Research

Published on 02 Sep 2020

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer

in Thoracic Oncology

Marco Maria Aiello
Cinzia Solinas
Matteo Santoni
Nicola Battelli
Nunzio Restuccia
Fiorenza Latteri
Sabrina Paratore
Francesco Verderame
Giuseppina Valeria Albanese
Paolo Bruzzi

Frontiers in Oncology

doi 10.3389/fonc.2020.01167

3,157 views
14 citations

Original Research

Published on 02 Sep 2020

A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer

in Thoracic Oncology

Wenfang Tang
Qingyi Hou
Juntao Lin
Dongjiang Li
Jieshan Lin
Jinghua Chen
Zhenbin Qiu
Xiangpeng Chu
Xiongwen Yang
Honghong Yan

Frontiers in Oncology

doi 10.3389/fonc.2020.01503

4,030 views
2 citations

Original Research

Published on 02 Sep 2020

Developing and Assessing the Effectiveness of a Nurse-Led Home-Based Educational Programme for Managing Breathlessness in Lung Cancer Patients. A Feasibility Study

in Thoracic Oncology

Aristides Choratas
Evridiki Papastavrou
Andreas Charalambous
Christiana Kouta

Frontiers in Oncology

doi 10.3389/fonc.2020.01366

8,767 views
12 citations

Original Research

Published on 25 Aug 2020

Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations

in Thoracic Oncology

Yijun Jia
Xuefei Li
Chao Zhao
Shengxiang Ren
Chunxia Su
Guanghui Gao
Wei Li
Fei Zhou
Jiayu Li
Caicun Zhou

Frontiers in Oncology

doi 10.3389/fonc.2020.01455

5,616 views
18 citations

Systematic Review

Published on 25 Aug 2020

Impact of Sex and Smoking on the Efficacy of EGFR-TKIs in Terms of Overall Survival in Non-small-Cell Lung Cancer: A Meta-Analysis

in Thoracic Oncology

Jian Xiao
Liang Zhou
Bixiu He
Qiong Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.01531

5,024 views
17 citations

Original Research

Published on 24 Aug 2020

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

in Thoracic Oncology

Minglei Zhuo
Tongtong An
Chaoting Zhang
Ziping Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.01584

5,324 views
28 citations

Correction

Published on 21 Aug 2020

Corrigendum: The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy

in Thoracic Oncology

Helen F. Titmarsh
Richard O'Connor
Kevin Dhaliwal
Ahsan R. Akram

Frontiers in Oncology

doi 10.3389/fonc.2020.01516

1,993 views
3 citations

Original Research

Published on 21 Aug 2020

Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma

in Thoracic Oncology

Qi-Wen Li
Bo Qiu
Wan-Ming Hu
Su-Ping Guo
Ying-Jia Wu
Yu-Jia Zhu
Nan Hu
Xin-Lei Ai
Nai-Bin Chen
Jin-Yu Guo

Frontiers in Oncology

doi 10.3389/fonc.2020.01487

3,420 views
7 citations

Case Report

Published on 21 Aug 2020

Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients

in Thoracic Oncology

Christian Britschgi
Alfredo Addeo
Markus Rechsteiner
Raphaël Delaloye
Martin Früh
Giulio Metro
Marco Banini
Oliver Gautschi
Sacha I. Rothschild
Peter J. Wild

Frontiers in Oncology

doi 10.3389/fonc.2020.01299

7,956 views
31 citations

Original Research

Published on 21 Aug 2020

Prevalence and Clinical Impact of Concomitant Mutations in Anaplastic Lymphoma Kinase Rearrangement Advanced Non-small-Cell Lung Cancer (Guangdong Association of Thoracic Oncology Study 1055)

in Thoracic Oncology

Meichen Li
Xue Hou
Chengzhi Zhou
Weineng Feng
Guanming Jiang
Hao Long
Shuang Yang
Jing Chen
Na Wang
Kaicheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.01216

9,157 views
17 citations

Original Research

Published on 19 Aug 2020

SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit

in Thoracic Oncology

Maria Lucia Reale
Paolo Bironzo
Valentina Bertaglia
Erica Palesandro
Gianmarco Leone
Fabrizio Tabbò
Maristella Bungaro
Marco Audisio
Annapaola Mariniello
Simonetta G. Rapetti

Frontiers in Oncology

doi 10.3389/fonc.2020.01722

5,420 views
6 citations

Original Research

Published on 12 Aug 2020

gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma

in Thoracic Oncology

Ellinor Peerschke
Kenneth Stier
Xiaoyu Li
Evelyn Kandov
Elisa de Stanchina
Qing Chang
Yuquan Xiong
Katia Manova-Todorova
Ning Fan
Afsar Barlas

Frontiers in Oncology

doi 10.3389/fonc.2020.01413

5,113 views
20 citations

Original Research

Published on 11 Aug 2020

A Greedy Algorithm-Based Stem Cell LncRNA Signature Identifies a Novel Subgroup of Lung Adenocarcinoma Patients With Poor Prognosis

in Thoracic Oncology

Seema Khadirnaikar
Annesha Chatterjee
Pranjal Kumar
Sudhanshu Shukla

Frontiers in Oncology

doi 10.3389/fonc.2020.01203

3,733 views
4 citations

Original Research

Published on 11 Aug 2020

Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma

in Thoracic Oncology

Fangyi Xu
Wenchao Zhu
Yao Shen
Jian Wang
Rui Xu
Chooah Outesh
Lijiang Song
Yi Gan
Cailing Pu
Hongjie Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.00872

8,378 views
45 citations

1,972 articles

articles

Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma

Integrated Analysis of lncRNA–Mediated ceRNA Network in Lung Adenocarcinoma

The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review

The Efficacy and Safety of First-Line Chemotherapy in Patients With Non-small Cell Lung Cancer and Interstitial Lung Disease: A Systematic Review and Meta-Analysis

Effective Treatment With Afatinib of Lung Adenocarcinoma With Leptomeningeal Metastasis Harboring the Exon 18 p.G719A Mutation in the EGFR Gene Was Detected in Cerebrospinal Fluid: A Case Report

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents

Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting

Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer

A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer

Developing and Assessing the Effectiveness of a Nurse-Led Home-Based Educational Programme for Managing Breathlessness in Lung Cancer Patients. A Feasibility Study

Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations

Impact of Sex and Smoking on the Efficacy of EGFR-TKIs in Terms of Overall Survival in Non-small-Cell Lung Cancer: A Meta-Analysis

Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients

Corrigendum: The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy

Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma

Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients

Prevalence and Clinical Impact of Concomitant Mutations in Anaplastic Lymphoma Kinase Rearrangement Advanced Non-small-Cell Lung Cancer (Guangdong Association of Thoracic Oncology Study 1055)

SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit

gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma

A Greedy Algorithm-Based Stem Cell LncRNA Signature Identifies a Novel Subgroup of Lung Adenocarcinoma Patients With Poor Prognosis

Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma